Effect of aragwadhadi kwath (kadha in Hindi) in treatment of mild corona virus disease
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: J100- Influenza due to other identifiedinfluenza virus with pneumonia
- Registration Number
- CTRI/2020/06/025796
- Lead Sponsor
- VaidhyaTushar Trivedi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Male or non-pregnant females aged >= 18 years with mild COVID-19 disease based on positive RT- PCR test.
2 Voluntary willingness of patient to give written informed consent prior to participation in trial.
Exclusion Criteria
1 Pregnant lady or Lactating mother
2 History of known hypersensitivity to study drugs
3 Corona positive patient with severe diarrhoea or Vomiting
4 Known case of Diabetes Mellitus
5 Participating in any other clinical trial or Receiving any other medicines of alternative system
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of Clinically and Virologically cured patientsTimepoint: at Day 5, 10 and 14
- Secondary Outcome Measures
Name Time Method Adverse effectsTimepoint: any;Change in RNA levels (Ct values) of SARS-CoV-2 from RT-PCRTimepoint: day 5, 10 and 14;Hospital stay durationTimepoint: any;Proportion of patients turned into severe category of diseaseTimepoint: At the end of study